New insights from Gordon Fraser spotlight a Triple Lipid Complex that supports skin barrier function, hydration, and ...

The practice introduces complementary CBCT-based 3D scans to support accurate dental implant evaluation and treatment ...

Abstract: The use of Signal Quality Monitoring (SQM) methods for the detection of global navigation satellite system (GNSS) spoofing has been extensively studied. However, existing SQM methods ...

Clinical trials suggest that selected nutraceuticals may improve sexual function; however, variable supplement quality and limited evidence constrain routine clinical use.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Knowledge breadth can be contextually relevant, or it can be too diffuse, increasing the ...

Since ecosystem services complement land, labor, and capital, their decline can lower economic output even when these other inputs increase. The bottom layer of Panel 1 (a) shows that ecosystem ...

— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — YARTEMLEA is the first and only approved ...

Investing.com -- Omeros Corporation (NASDAQ:OMER) stock rose 3.1% on Tuesday after the company announced it has completed its first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors ...

Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA ® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant ...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of ...

It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...